iBio Inc Says On Sept 15, Unit Entered Into Purchase And Sale Agreement With Majestic Realty To Sell CGMP Biologics Manufacturing Facility; Purchase And Sale Agreement Provides That Unit's Property Will Be Sold To Majestic Realty For $17.25M
Portfolio Pulse from Benzinga Newsdesk
iBio Inc's unit has entered into a purchase and sale agreement with Majestic Realty to sell its CGMP Biologics Manufacturing Facility for $17.25M.
September 21, 2023 | 12:07 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
iBio Inc's unit is selling its CGMP Biologics Manufacturing Facility to Majestic Realty for $17.25M, which could impact the company's assets and revenues.
The sale of the CGMP Biologics Manufacturing Facility by iBio's unit could potentially impact the company's assets and revenues. However, it's unclear whether this will have a positive or negative impact on the company's stock price in the short term, as it depends on how the company plans to use the proceeds from the sale.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100